NAMS 2023 Nonhormone Therapies Position Statement for Bothersome Menopause Symptoms is the latest video in the North American Menopause Society’s Video Series-2023.

NAMS 2023 Nonhormone Therapies Position Statement Video

What does the North American Menopause Society (NAMS) explain in their latest video, NAMS 2023 Nonhormone Therapies Position Statement for Bothersome Menopause Symptoms?

In Video Series-2023 the NAMS explain:

“In this latest video, NAMS 2023 Nonhormone Therapies Position Statement for Bothersome Menopause Symptoms, Dr. Shapiro interviews Dr. Chrisandra Shufelt, NAMS Immediate Past-President; Professor and Chair, Division of General Internal Medicine; and Associate Director, Women’s Health Research Center at the Mayo Clinic in Jacksonville, Florida”.

The 2023 Nonhormone Therapy Position Statement of The North American Menopause Society

What were the Results in The 2023 Nonhormone Therapy Position Statement of The North American Menopause Society?

On page one in the The 2023 Nonhormone Therapy Position Statement of The North American Menopause Society: Abstract – Results, published May 2023, the results were:

Results: Evidence-based review of the literature resulted in several nonhormone options for the treatment of vasomotor symptoms.

Recommended: Cognitive-behavioral therapy, clinical hypnosis, selective serotonin reuptake inhibitors/serotonin-norepinephrine reuptake inhibitors, gabapentin, fezolinetant (Level I); oxybutynin (Levels I-II); weight loss, stellate ganglion block (Levels II-III).

Not recommended: Paced respiration (Level I); supplements/herbal remedies (Levels I-II); cooling techniques, avoiding triggers, exercise, yoga, mindfulness-based intervention, relaxation, suvorexant, soy foods and soy extracts, soy metabolite equol, cannabinoids, acupuncture, calibration of neural oscillations (Level II); chiropractic interventions, clonidine; (Levels I-III); dietary modification and pregabalin (Level III)”.

What do the Levels mean in the 2023 Nonhormone Therapy Position Statement of The North American Menopause Society?

On page one in the The 2023 Nonhormone Therapy Position Statement of The North American Menopause Society: Abstract – Methods the North American Menopause Society (NAMS) elaborate on:

Methods: The panel assessed the most current and available literature to determine whether to recommend or not recommend use based on these levels of evidence:

  • Level I, good and consistent scientific evidence
  • Level II, limited or inconsistent scientific evidence
  • Level III, consensus and expert opinion”.

Health Topics A-Z

Where may I find Health Topics A-Z related to NAMS 2023 Nonhormone Therapies Position Statement Video?

In Health Topics A-Z you may find:

Links

Where may I find Links related to NAMS 2023 Nonhormone Therapies Position Statement Video?

Your Country may have Links similar to:

Last Updated: 01 June 2023 – Last Revised: 31 May 2023